ArticleOncoimmunology

Antagonist of cIAP1/2 and XIAP enhances anti-tumor immunity when combined with radiation and PD-1 blockade in a syngeneic model of head and neck cancer.

Roy Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.